These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3198165)

  • 1. Biodistribution and plasma protein binding of 2-formyl-1-methyl pyridinium methiodide (2-PAM) in sheep (Ovis aries).
    Srivastava AK; Malik JK
    Indian J Exp Biol; 1988 Aug; 26(8):643-4. PubMed ID: 3198165
    [No Abstract]   [Full Text] [Related]  

  • 2. Disposition kinetics of 2-pyridine aldoxime methochloride in Bubalus bubalis.
    Srivastava AK; Malik JK
    J Vet Pharmacol Ther; 1989 Mar; 12(1):103-8. PubMed ID: 2704055
    [No Abstract]   [Full Text] [Related]  

  • 3. Disposition kinetics and dosage regimen of 2-formyl 1-methyl pyridinium oxime (2-PAM) in heifers.
    Srivastava AK; Khanikor HN; Malik JK
    Acta Vet Hung; 1988; 36(3-4):251-6. PubMed ID: 3254091
    [No Abstract]   [Full Text] [Related]  

  • 4. Disposition kinetics and urinary excretion of 2-pyridine aldoxime methiodide in sheep.
    Srivastava AK; Malik JK
    Vet Rec; 1989 Oct; 125(17):436-7. PubMed ID: 2588454
    [No Abstract]   [Full Text] [Related]  

  • 5. Paraoxon has only a minimal effect on pralidoxime brain concentration in rats.
    Petroianu GA; Lorke DE; Hasan MY; Adem A; Sheen R; Nurulain SM; Kalasz H
    J Appl Toxicol; 2007; 27(4):350-7. PubMed ID: 17265425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HI-6 and 2-PAM in sheep: pharmacokinetics and effects on muscle tissue following intramuscular injection.
    Moore DH; Hayward IJ; Tucker FS; Lukey B
    Biopharm Drug Dispos; 1991 Apr; 12(3):223-32. PubMed ID: 2059672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What target pralidoxime concentration?
    Dawson A; Buckley N; Whyte I
    J Toxicol Clin Toxicol; 1997; 35(2):227-30. PubMed ID: 9120899
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antidose therapy for organophosphate poisoning].
    Iseki K
    Chudoku Kenkyu; 2008 Apr; 21(2):151-9. PubMed ID: 18516940
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacokinetics of continuous infusion pralidoxime in children with organophosphate poisoning.
    Schexnayder S; James LP; Kearns GL; Farrar HC
    J Toxicol Clin Toxicol; 1998; 36(6):549-55. PubMed ID: 9776957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pralidoxime iodide (2-pAM) penetrates across the blood-brain barrier.
    Sakurada K; Matsubara K; Shimizu K; Shiono H; Seto Y; Tsuge K; Yoshino M; Sakai I; Mukoyama H; Takatori T
    Neurochem Res; 2003 Sep; 28(9):1401-7. PubMed ID: 12938863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of UV spectroscopic, chromatographic, and electrophoretic methods for the cholinesterase reactivating antidote pralidoxime (2-PAM).
    John H; Blum MM
    Drug Test Anal; 2012; 4(3-4):179-93. PubMed ID: 21953823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular kinetics and dosage regimens for pralidoxime in buffalo calves (Bubalus bubalis).
    Srivastava AK; Malik JK
    Vet Res Commun; 2001 May; 25(4):301-9. PubMed ID: 11432431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
    Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
    J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve agent toxicology.
    Wood SP
    JEMS; 2003 Dec; 28(12):16; author reply 16. PubMed ID: 14702965
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxogonin and pralidoxime: kinetic comparison after intravenous administration to man.
    Sidell FR; Groff WA; Kaminskis A
    J Pharm Sci; 1972 Nov; 61(11):1765-9. PubMed ID: 4569114
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood-brain barrier penetration of novel pyridinealdoxime methiodide (PAM)-type oximes examined by brain microdialysis with LC-MS/MS.
    Okuno S; Sakurada K; Ohta H; Ikegaya H; Kazui Y; Akutsu T; Takatori T; Iwadate K
    Toxicol Appl Pharmacol; 2008 Feb; 227(1):8-15. PubMed ID: 17964625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase inhibition in the crayfish Procambarus clarkii exposed to fenitrothion.
    Escartín E; Porte C
    Ecotoxicol Environ Saf; 1996 Jul; 34(2):160-4. PubMed ID: 8812182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase inhibition by aluminium phosphide poisoning in rats and effects of atropine and pralidoxime chloride.
    Mittra S; Peshin SS; Lall SB
    Acta Pharmacol Sin; 2001 Jan; 22(1):37-9. PubMed ID: 11730559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accidental injection of a U.S. Air Force aviator by a pralidoxime chloride auto-injector: a case report.
    Yamane GK
    Aviat Space Environ Med; 1999 Nov; 70(11):1110-2. PubMed ID: 10608609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.